Producătorul de medicamente şi suplimente Biofarm (simbol bursier BIO) a încheiat anul 2023 cu profit net de aproximativ 77 milioane lei, cu 8,6% mai mare decât în 2022, conform rezultatelor preliminare (neauditate), consultate de Economica.net.
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2023/11/biofarm-858x417.jpg)
catalin vicol
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2022/09/BIOFARM_DAY2-8776-630x420.jpg)
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2022/09/BIOFARM_DAY2-7045-630x420.jpg)
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2022/02/BIOFARM-630x420.jpg)
